RE: Deutsche Bank initiates coverage of Synairgen9 May 2024 11:48
TP - Based on previous years, the Full Year Results for 2023 are due within the next couple of weeks. Hopefully this will include information - hopefully on the positive side - about the p2 trials and how things are progressing. This report should also include the "going concern" portion which Spacman has mentioned on a few occasions, and again, hopefully this should give some clues at least on how things are going. I wouldn't be surprised to hear of further slippages/curve-balls/obfuscation etc.
As for the AGM, I'm more skeptical than ever that this will yield any further useful tidbits for investors. It is clear that for whatever reason, following last years AGM, Synairgen have essentially decided to shut up shop in terms of any communication at all to shareholders. In fact on this point, I do wonder whether they will even grace us with a face-to-face meeting at all this year...
ATB & GLA.